Blue Horseshoe Stocks: Celebrating 6 Years!

Happy Anniversary to Us!

First thing’s first- today marks the SIX YEAR anniversary of when we launched BlueHorseshoeStocks.com, our home on the web, and place to store and make available every single newsletter we’ve ever sent out during that time! We’ve unfailingly brought ideas to the table every trading day since then and want to take this opportunity to thank all of our readers who we value so much. From the most loyal who have been with us from the beginning, to every single person we picked up along the way. Cheers to all!


GoPro, Inc. GPRO

We put a set of options on watch for GPRO on Friday morning, and the potential single session gains that were there for the taking ranged from very good to downright fantastic!

Our highlighted range was the GPRO Weekly $9-10 Calls, and the intraday move that the stock itself made from a low of 9.31 up as high as 10.38, facilitated the following gain opportunities:

$9 Calls – Range: .34-1.35 – Max Gain: 297%
$9.50 Calls – Range:.13-.84 – Max Gain: 546%
$10 Calls – Range:.01-.40 – Max Gain: 3900%

As you can see, the chances for profits were exponentially greater, the higher the strike price chosen, but all around the idea turned out to be solid no matter what.


Eros International, plc EROS

We want to place EROS on watch as a possible bottom-bounce play this morning, after noticing a couple of different factors at work. The stock spent the past several sessions getting pummeled down to new 52-week lows, which in itself would be enough to catch our attention.

This morning we’re seeing a notable gap-up in the premarket, on the news that the Indian film company has entered preliminary talks with Apple to sell its entire content library. (>>View PR)

The stock was recently trading in the $14 range, and a return to that level does not seem out of the question, so we want to keep an eye on EROS as we kick off a new trading week.
.


Extended Watchlist:
IIVI, AKS, XXII, CRNT, CLNT, ATHX, CYCC, XNET

Blue Horseshoe Stocks: Stellar Options Calls & More

Valeant Pharmaceuticals, Inc. VRX – Options Recap

In yesterday morning’s premarket report, we noted that VRX had been coming off of recent annual lows, had a beat on earnings, and was up considerably in early trading.

Our exact words were “We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.” Things did play out similarly. We did indeed see considerable gains, and quite frankly, that’s an understatement.

As VRX itself traded from 10.57 to 12.43, our targeted options calls posted astronomical moves on the day, giving traders a chance to grab a piece of the following gains:

$10.50 Calls – Range: .40-.1.92 – Max Gain: 380%
$11 Calls – Range: .18-1.50 – Max Gain: 733%
$11.50 Calls – Range: .08-1.05 – Max Gain: 1212%
$12 Calls – Range: .02-.74 – Max Gain: 3600%

This wasn’t even the first percentage gain in the thousands that we’ve rooted out in the past week. The SPY Weekly $238-50-239.50 Calls that we highlighted in Friday morning’s premarket report yielded a 4600% gainer on that day. Both of these plays serve as perfect examples of why we don’t limit our daily reports to stocks alone.


Cleantech Solutions International, Inc. CLNT

We did have a very nice play on the stock side of things as well yesterday, after we tagged CLNT in our extended watchlist. It ended up making a solid early push from a low of 4.11, and ran as high as 6.99 inside the first hour of trading.

That was good for intraday gains of up to 70% which we feel is quite good for a stock in this price range. CLNT is pulling back in premarket, but we will remain interested in possible bounce activity in the event that it holds support above yesterday’s swing low.



Proteon Therapeutics, Inc. PRTO

There’s an interesting situation unfolding with PRTO that warrants placing the stock on watch today. Despite reporting Q1 losses of $6.5M, the stock is gapping up heavily on the strength of a concurrent announcement. It pertains to the fact that the company’s investigatory treatment, vonapanitase, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA).

Whenever such FDA news hits wires the resultant activity on the chart is sure to be interesting, which is evidenced by the the fact that traders are ignoring the disappointing quarterly figures that coincided with this event. Thus we are eager to track PRTO as we head through midweek.


Extended Watchlist:
ASTI, BZUN, LBIO, AAXN, ARGS, MTBC, REXX

Blue Horseshoe Stocks: Bottom-Plays, Options & More

Celadon Group, Inc. CGI

We’ve been seeing a fair bit of bottom-bouncers running across our desks this week, and CGI is the latest to grab our attention. What we’ve got here is a very enticing chart with just about everything we look for in a potential bottom play.

The stock is beginning to come off of being massively oversold, has set higher lows and higher highs for each of the last three sessions, and has a sizable gap to fill to the upside. We also have a MACD that appears as if a bullish cross could be forthcoming, so we’ll definitely want to keep an eye on CGI this week.


____

Two other stocks on our bottom watchlist, California Resources Corp. and CRC Uni-Pixel, Inc. UNXL will remain there. We signaled these two just yesterday, and despite recording only marginal gains on the day, we still want to leave them a spot on our radar as well.



Valeant Pharmaceuticals, Inc. VRX – Options Idea

Speaking of bottom-bouncers, VRX recently rebounded off of new 52-week lows, and is hitting our scanners this morning.  With a pleasing Q1 earnings call which included solid boosts in profits for the quarter as well as reinforced guidance for the remainder of the year, VRX is gapping up considerably in the premarket.

We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.


Extended Watchlist:
AMRS, ARLZ, CLNT, MTBC, XXII, ORRV(News)

Incoming search terms:

  • rillenschiene amrs 60 r 1

Blue Horseshoe Stocks: KMX Options Update & More

CarMax, Inc. KMX – Options Idea

We formulated several targets in the KMX options chain yesterday morning in accordance with the solid earnings beat and premarket gap-up we were observing.   We specified some medium and longer-term contracts with the KMX C$57.50 and $60 Calls, and the 05/19 $60-$65 Calls. We were more than pleased with the activity that ensued.

We’re usually pretty good with our targeting, and these ideas were no exception. Every single one of the contracts we mentioned provided traders with the chance for some very nice single-session gains.

04/21 $57.50 Calls – Range: .45-1.70 – Max Gain: 278%
04/21 $60 Calls – Range:  .17-.75 – Max Gain: 341%

05/19 $60 Calls – Range: .68-1.54 – Max Gain: 126%
05/19 $62.50 Calls – Range: .28-.82- Max Gain: 193%
05/19 $65 Calls – Range: .11-.38 – Max Gain: 245%

With that kind of activity on the very first day, we’re definitely going to want to keep these plays in mind going forward. There may yet be more opportunities still to come.


Akari Therapeutics, Plc. AKTX

We tagged AKTX in yesterday morning’s extended watchlist and saw a very nice intraday performance. It traded in a daily range from a low of 13.69 to a high of 18.46, which represents a 35% spike on the day.

That move came on more than thirteen times the three-month average volume. On the whole, the activity in AKTX was extremely impressive, especially for a stock in its price range. The stock failed to maintain the majority of its daily advance, but we’ll remain interested provided it can register a higher base level of support to close out the week today.



In Ovations Holdings, Inc. INOH

We’re going to begin monitoring this super-subpenny stock after it just reappeared with its first filings in quite some time; two quarterlies and an annual report can be found at the company’s OTC Market filings page (>>View Filings). The filings bring the company current on its financial reporting.

We’ve seen a number of triple-zero stocks make exponential gains in recent weeks, and want to take a flyer on INOH on the outside chance that it could be the next rocket to leave the launchpad!


Extended Watchlist:
GBSN, CLNT, MNKD, SALT, SBLK, CBR,

Blue Horseshoe Stocks: ACGX, SKYF & Extended Watchlist


Alliance Creative Group, Inc. ACGX

We’re looking to ACGX once again this week- If you recall, back in April this stock brought us chances for significant gains as it ran 100% from .0055 up to .011.

We followed up early this month where we put the a stock on bottom-watch. Since then, it has consolidated down to find that solid support we were looking for at .0035 and has begun to rebound.

Yesterday ACGX cracked back above its 50DMA at .005, and that’s where we’d like to see support hold from here. There’s some key resistance coming up in the .007-.008 range; if ACGX can make a move back to pennyland, it will spell gains of 65% or more, so we definitely want to continue monitoring this play in upcoming sessions.

We’ve prepared a short video presentation of the chart, click below and take a look:



SKY440, Inc. SKYF

Congratulations are in order for anyone following along with our call of SKYF earlier in the week. After making a 100% intraday run from .0012 to .0024 following our initial alert, the stock came back to bounce off of support at .001 yesterday morning. It subsequently ran back to .0018, tacking on another 80% to the gains we’d already observed.

One of the things we’re not crazy about with SKYF is the Caveat Emptor status designated to it over at OTCMarkets.com. We’d like to see that info get updated, although there has been no indication that the process is underway.

In the meantime, chart-wise, key resistance in the .0022-.0024 range must be broken, or we’ll consider taking profits off of the table and moving on. Additionally, support will need to continue to hold at or above .001 to keep SKYF an item of interest.



Extended Watchlist:
SRC, GTIV, PTX, CLNT, PERI, RNBI